LeonaBio, Inc. business relationships
Companies named in LeonaBio, Inc.’s 10-K filed 2026-03-31, and public companies whose annual reports name LeonaBio, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 6% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in LeonaBio, Inc.’s annual report 4
“Lasofoxifene was discovered through a research collaboration between Pfizer Inc. ("Pfizer") and Ligand Pharmaceuticals ("Ligand").” SEC filing
“License Agreement between Ligand Pharmaceuticals Incorporated and Athira Pharma, Inc. dated December 18, 2025” SEC filing
“Lasofoxifene was discovered through a research collaboration between Pfizer Inc. ("Pfizer") and Ligand Pharmaceuticals ("Ligand").” SEC filing
“As discussed in Notes 3 and 4 to the consolidated financial statements, in connection with the Company's December 2025 license agreement with Sermonix Pharmaceuticals, Inc. ("Sermonix"), the Company recognized a” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.